U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06800677) titled 'Methylated Biomarkers Predictive of Endometrial Cancer Risk' on July 31, 2024.
Brief Summary: The goal of this observational study is to identify endometrial cancer risk predictive biomarkers and to optimise the methodology for their detection and quantification in non-invasive samples.
Study Start Date: July 31, 2024
Study Type: OBSERVATIONAL
Condition:
Endometrial Cancer
Intervention:
PROCEDURE: Hysterectomy
Elective hysterectomy
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: University of Manchester
Information provided by (Responsible Party): Sarah Kitson, University of Manchester
Disclaimer: Curated by HT Syndica...